nausea tirzepatide vs semaglutide Ozempic: Side Effects Comparison Semaglutide and Tirzepatide Side Effects

Patients interested in trying GLP-1 weight loss drugs will need to visit their primary care providers to determine eligibility

The future of obesity care depends not only on expanding access to effective treatments, but on ensuring those treatments are delivered through evidence-based, patient-centered care that prioritizes safety, trust, and long-term health

Eli Lilly is aggressively capitalizing on its significant first-mover advantage in the obesity market with its blockbuster GLP-1 drugs, Zepbound and Mounjaro

The article's concern is effectiveness rather than toxicity

A recent study showed that subtype 1b remained the most prevalent and widely distributed genotype in China (35)

Many of our patients have experienced dramatic improvements in their overall health, even the ability to come off certain medicationsthey previously relied on